High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Larkin KT, Nicolet D, Kelly BJ, Mrózek K, LaHaye S, Miller KE, Wijeratne S, Wheeler G, Kohlschmidt J, Blachly JS, Mims AS, Walker CJ, Oakes CC, Orwick S, Boateng I, Buss J, Heyrosa A, Desai H, Carroll AJ, Blum W, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Paskett ED, Byrd JC, Mardis ER, Eisfeld AK.
Larkin KT, et al. Among authors: kohlschmidt j.
Blood Adv. 2022 Oct 11;6(19):5570-5581. doi: 10.1182/bloodadvances.2022007544.
Blood Adv. 2022.
PMID: 35788257
Free PMC article.